Asia-Pacific Cancer Spit Test Device Market, By Product Type (Saliva Collection Kits, Fluid Specific Devices, Oral Swab, Bar-Code Labels, Saliva Cryostorage Box, and Others), Site of Collection (Sub-Mandibular/Sub-Lingual Gland, Parotid Gland, and Minor Salivary Gland), Application (Liver-lung Cancer, Breast Cancer, Colon And Rectal Cancer, Prostate Cancer, Pancreatic Cancer, Oral Cancer, Thyroid Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Melanoma, Non-Hodgkin Lymphoma and Others), Age Group (Adult and Pediatric), Method of Collection (Passive Drool, Oral Swab and Others), End User (Hospitals, Diagnostic Laboratories, Oncology Speciality Clinics, Cancer Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales and Others) Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Asia-Pacific Cancer Spit Test Device Market
Asia-Pacific cancer spit test device market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Asia-Pacific cancer spit test device market is growing with a CAGR of 10.5% in the forecast period of 2021 to 2028 and is expected to reach USD 209.46 million by 2028 from USD 98.48 million in 2020. Rising prevalence of chronic diseases and increasing number of cancer patients are major drivers, which are expected to propel the growth of the market in the forecast period.
A saliva test is nowadays extensively used for cancer detection. A cancer saliva would test for the presence or absence of mutated extra-cellular DNA and RNA. The tumor cells shed DNA and RNA into the circulation and they come into saliva, and mutations are detectable with great accuracy in saliva.
The cancer saliva test devices market comprises testing kits, swabs, cassettes, and devices used for the detection of drugs, infections, or diseases in human beings. Several types of kits utilize different types of molecular biology methods for disease detection. ELISA, PCR, immunoassay, and enzymatic assays among others are molecular techniques that are used for saliva testing.
The Asia-Pacific cancer spit test device market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Asia-Pacific Cancer Spit Test Device Market Scope and Market Size
Asia-Pacific cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the Asia-Pacific cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others. In 2021, saliva collection kits segment is expected to dominate the market due to rising prevalence of cancer and growing geriatric population in the region.
- On the basis of site of collection, the Asia-Pacific cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market owing to its non-invasive method and ease in collection.
- On the basis of application, the Asia-Pacific cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market owing to rising environmental pollution and growing substance abuse among people.
- On the basis of age group, the Asia-Pacific cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to rising prevalence of different types of cancers among elderly population.
- On the basis of method of collection, the Asia-Pacific cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market as it could be easily self-collected.
- On the basis of end user, the Asia-Pacific cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market because of rising number of cancer cases and growing awareness among people regarding the disease.
- On the basis of distribution channel, the Asia-Pacific cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to broad range of products availability and growing pool of cancer patients in the region.
Asia-Pacific Cancer Spit Test Devices Market Country Level Analysis
The Asia-Pacific cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.
Countries covered in the Asia-Pacific cancer spit test device market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific, The Asia-Pacific region is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 owing to rising prevalence of cancer cases in the region. China is dominating the Asia-Pacific market due to rising disposable income in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the Asia-Pacific Cancer Spit Test Devices Market
Saliva collection kits segment is dominating in China, which is leading in the Asia-Pacific region owing to growing geriatric population.
Asia-Pacific cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the Asia-Pacific cancer spit test device market sales, impact of advancement in the Asia-Pacific cancer spit test device market and changes in regulatory scenarios with their support for the Asia-Pacific cancer spit test devices market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Asia-Pacific Cancer Spit Test Device Market Share Analysis
Asia-Pacific cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided is only related to the companies’ focus related to Asia-Pacific cancer spit test devices market.
Major players covered in the report are DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG, Miraclean Technology Co.,Ltd., Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Oasis Diagnostics Corporation, and Canvax ( a subsidiary of dobuss) among other domestic and Asia-Pacific players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the Asia-Pacific cancer spit test device market.
For instance,
- In January 2021, DNA Genotek announced that the U.S. Food and Drug Administration (FDA) has granted a general use 510(k) clearance for its OrageneDx family of products. This FDA approval increased the credibility of the company in the market and increased the demand for this product.
- In February 2021, Thermo Fisher Scientific was recognized with six CMO Leadership Awards. It won across all six categories including: capabilities, compatibility, expertise, quality, reliability, and service. This is the second consecutive year Thermo Fisher has received this recognition across all six categories and the eighth time overall that the company has been honored by the CMO Leadership Awards. This has increased the credibility of the company and aided in revenue generation.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORKS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN CANCER BURDEN WORLDWIDE
6.1.2 INCREASE IN INITIATIVES BY GOVERNMENT AND OTHER HEALTHCARE ORGANIZATIONS
6.1.3 RISE IN GERIATRIC POPULATION
6.1.4 RISE IN PRODUCT APPROVALS AND LAUNCHES FOR CANCER
6.1.5 RISE IN EXPENDITURE ON HEALTHCARE
6.2 RESTRAINTS
6.2.1 INCREASE PREVALENCE OF COVID-19
6.2.2 LACK OF EARLY DETECTION
6.3 OPPORTUNITIES
6.3.1 RECOMMENDATIONS FOR CANCER SCREENING
6.3.2 RISE IN DEMAND OF POINT-OF-CARE TESTING
6.3.3 RISE IN R&D ACTIVITIES
6.4 CHALLENGES
6.4.1 STRINGENT REGULATION POLICY
6.4.2 RISING COMPETITION AMONG MARKET PLAYERS
7 IMPACT OF COVID-19 THE ON ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET
7.1 IMPACT ON SUPPLY CHAIN
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS FOR MANUFACTURERS
7.4 CONCLUSION
8 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SALIVA COLLECTION KIT
8.2.1 DNA EXTRACT
8.2.2 RNA EXTRACT
8.3 FLUID SPECIFIC DEVICES
8.4 ORAL SWAB
8.5 BAR-CODE LABELS
8.6 SALIVA CRYOSTORAGE BOX
8.7 OTHERS
9 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION
9.1 OVERVIEW
9.2 SUB-MANDIBULAR/SUB-LINGUAL GLAND
9.3 PAROTID GLAND
9.4 MINOR SALIVARY GLAND
10 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 LIVER-LUNG CANCER
10.3 BREAST CANCER
10.4 COLON AND RECTAL CANCER
10.5 PROSTATE CANCER
10.6 PANCREATIC CANCER
10.7 ORAL CANCER
10.8 THYROID CANCER
10.9 ENDOMETRIAL CANCER
10.1 KIDNEY CANCER
10.11 LEUKEMIA
10.12 MELANOMA
10.13 NON-HODGKIN LYMPHOMA
10.14 OTHERS
11 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 PEDIATRICS
12 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY METHOD OF COLLECTION
12.1 OVERVIEW
12.2 PASSIVE DROOL
12.3 ORAL SWAB
12.4 OTHERS
13 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC LABORATORIES
13.4 ONCOLOGY SPECIALITY CLINICS
13.5 CANCER RESEARCH INSTITUTES
13.6 OTHERS
14 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 OTHERS
15 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY REGION
15.1 ASIA-PACIFIC
15.1.1 CHINA
15.1.2 INDIA
15.1.3 SOUTH KOREA
15.1.4 AUSTRALIA
15.1.5 JAPAN
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 BIOCARTIS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 BD
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENT
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 F. HOFFMANN-LA ROCHE LTD
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 QIAGEN
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AGILENT TECHNOLOGIES, INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 BIOMÉRIEUX SA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANVAX
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 COLOR HEALTH, INC.
18.9.1 1.6.1 COMPANY SNAPSHOT
18.9.2 1.6.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 DNA GENOTEK
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENT
18.11 ILLUMINA, INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 MIRACLEAN TECHNOLOGY CO.,LTD.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 OASIS DIAGNOSTICS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 PERIRX
18.14.1 COMPANY SNAPSHOT
18.14.2.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 SALIMETRICS, LLC
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 SARSTEDT AG & CO. KG
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 THERMO FISHER SCIENTIFIC INC.
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.
TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.
TABLE 3 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC FLUID SPECIFIC DEVICES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC BAR-CODE LABELS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC SALIVA CRYOSTORAGE BOX IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC SUB-MANDIBULAR/SUB-LINGUAL GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC PAROTID GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC MINOR SALIVARY GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC LIVER-LUNG CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC BREAST CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC COLON AND RECTAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC PROSTATE CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC PANCREATIC CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC ORAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC THYROID CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC ENDOMETRIAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC KIDNEY CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC LEUKEMIA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC MELANOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC NON-HODGKIN LYMPHOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC ADULT IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC PEDIATRICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC PASSIVE DROOL IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC HOSPITALS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC DIAGNOSTIC LABORATORIES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC ONCOLOGY SPECIALITY CLINICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC CANCER RESEARCH INSTITUTES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC DIRECT TENDER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC RETAIL SALES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 CHINA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 CHINA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 57 CHINA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 58 CHINA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CHINA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 60 CHINA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 61 CHINA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 CHINA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 63 INDIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 INDIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 INDIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 66 INDIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 INDIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 68 INDIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 69 INDIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 INDIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 SOUTH KOREA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 74 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 76 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 79 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 AUSTRALIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 81 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 82 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 84 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 85 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 87 JAPAN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 88 JAPAN SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 89 JAPAN CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 90 JAPAN CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 91 JAPAN CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 92 JAPAN CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 93 JAPAN CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 94 JAPAN CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 95 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 96 SINGAPORE SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 97 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 98 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 100 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 101 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 102 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 103 THAILAND CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 104 THAILAND SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 105 THAILAND CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 106 THAILAND CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 107 THAILAND CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 108 THAILAND CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 109 THAILAND CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 110 THAILAND CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 116 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 117 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 118 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 119 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 120 INDONESIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 125 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 126 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 127 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 128 PHILIPPINES SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 129 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 130 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 131 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 132 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 133 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 134 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 135 REST OF ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 2 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 SALVIA COLLECTION KIT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET
FIGURE 14 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 15 ESTIMATED AGE-STANDARDIZED INCIDENCE RATES (WORLD) IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 16 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2020
FIGURE 17 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 18 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 19 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2020
FIGURE 21 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, CAGR (2021-2028)
FIGURE 23 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2020
FIGURE 25 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 27 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2020
FIGURE 29 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2021-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, CAGR (2021-2028)
FIGURE 31 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2020
FIGURE 33 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, CAGR (2021-2028)
FIGURE 35 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, 2020
FIGURE 37 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, 2021-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, CAGR (2021-2028)
FIGURE 39 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 41 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 42 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 43 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : SNAPSHOT (2020)
FIGURE 45 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY COUNTRY (2020)
FIGURE 46 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY COUNTRY (2021 & 2028)
FIGURE 47 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY COUNTRY (2020 & 2028)
FIGURE 48 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY PRODUCT TYPE (2021-2028)
FIGURE 49 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
